A modest opening with room to breathe

“Clayface” earned $24 million in its opening weekend, a modest result that may still count as a useful win for DC Studios. The body-horror film centers on a lesser-known comic-book character, and its $44 million production budget gives it more room to perform than a typical superhero tentpole. That budget changes how the opening should be read: a film doesn’t need to match the huge totals associated with the genre’s biggest names to have a plausible path to success. It does need enough audience interest to keep the theatrical run going, and one weekend can’t establish that on its own.

The opening fell just short of forecasts, which had put the film between $25 million and $30 million. It did, however, beat the second weekend of A24’s “You Can See Everything,” which brought in $19.5 million. For a niche character in a gory genre rarely associated with superhero films, that’s a respectable start. The film may not become a major profit engine, but its relatively low cost limits the downside. The gap from expectations is real, though: a modest miss is still a miss, and the next question is whether the film can hold attention beyond its first wave of viewers.

A steadier result for Gunn and Safran

The numbers look better beside DC’s previous release under James Gunn and Peter Safran. “Supergirl” was estimated to have lost between $80 million and $120 million, and critics were less receptive: it holds a 52% “rotten” rating on Rotten Tomatoes, compared with “Clayface” at 75% “fresh.” The comparison isn’t a full measure of either film’s prospects, since critical response and box-office performance don’t move in lockstep. But it does show why a lower-cost film with a warmer reception can matter to a studio trying to build confidence in its slate.

“Superman,” which Gunn wrote and directed last summer, remains the strongest example of the pair’s bright, irreverent approach. It earned $618.7 million worldwide and won broad critical approval. DC’s streaming series, including “Lanterns” and “Peacemaker,” have also fared better with critics. Those projects point to a creative operation with more than one tone available to it. “Clayface” tests whether that range can include a darker, more physically unsettling story without asking audiences to show up for a familiar headliner.

Still, the studio hasn’t approached the theatrical peaks set by earlier DC films. Two entries in Christopher Nolan’s “The Dark Knight” trilogy and the first “Aquaman” each passed $1 billion worldwide; “Wonder Woman” made $823.9 million. Gunn and Safran took charge while the brand was struggling with consistency, after films such as “Aquaman and the Lost Kingdom” and “The Flash” drew little audience interest. Their releases have improved on that low point, though they haven’t yet matched the unruly comic energy of Gunn’s “Guardians of the Galaxy” films. A stronger baseline is useful, but it isn’t the same as a reliable run of hits.

Safran, whose producing credits include “The Conjuring” franchise, is regarded as the operation’s business lead. Gunn brings deep comic-book knowledge and sets its creative direction. “Clayface” suggests their slate can find an audience without relying on a familiar hero or a massive budget, even if it hasn’t yet delivered a defining box-office hit. That’s a meaningful test of the strategy: can a DC release succeed on its own identity, rather than borrowing momentum from a character audiences already know? This is more significant than it looks, though the opening alone can’t settle the question.

Audiences are choosier about superhero films

The challenge extends beyond DC. Comic-book audiences appear more selective, and even Marvel has struggled to build momentum around newer teams. “Thunderbolts,” “The Fantastic Four: First Steps,” “The Eternals” and “The Marvels” have disappointed at the box office, with some becoming outright flops, according to industry reporting. That pattern suggests the genre’s label no longer does as much work as it once did. Viewers may still be interested in superhero stories, but a familiar format or shared universe can’t guarantee that they’ll buy a ticket.

Established characters and returning stars still draw attention. “Spider-Man: Brand New Day” has earned $2.5 billion, while “Avengers: Doomsday” is expected to be a major release with Robert Downey Jr. and Chris Evans returning. DC’s next prospects include “The Batman: Part II” in 2028 and Gunn’s “Man of Tomorrow” next summer. These titles have a different kind of built-in recognition from “Clayface,” giving the studio a useful contrast: the smaller film can show whether audiences will follow an unusual premise, while the larger releases will test the pull of familiar characters and returning talent.

What the opening can—and can’t—tell DC

Those films will test whether DC can turn stronger individual releases into a dependable theatrical run. For now, “Clayface” offers a smaller measure of progress: a below-forecast opening, a comparatively restrained budget and a better critical reception than “Supergirl.” In a market where even Marvel’s newer properties are struggling, that may be enough to make this a qualified win. It’s not proof that audiences will embrace every corner of DC’s slate, but it gives the studio a reason to keep testing different kinds of stories.

Here’s the thing: a lower-cost film can make experimentation easier to justify, but it can’t make audience demand optional. The opening needs to be followed by enough sustained interest to support the film’s prospects, and the available figures don’t yet tell us whether that will happen. If you’re working in this space, the signal to watch is whether DC’s distinct projects can draw viewers for their own reasons, rather than depending on the same blockbuster formula each time. A small win. A useful clue, not a verdict.

And yet, “Clayface” matters precisely because it occupies a less predictable lane. If the film finds an audience, DC can point to a release that didn’t need a familiar hero or an enormous production budget to get attention. If it doesn’t, the opening will still show that a comparatively restrained cost can limit the scale of the risk, but not erase it. That distinction is easy to lose in a business that tends to frame every release as either a triumph or a failure (and this is the part most people overlook). The more telling measure will be whether the studio can repeat this kind of result across projects with different tones and audiences.